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SUPERIOR VENA CAVA SYNDROME CAUSED BY PULMONARY ARTERY SARCOMA
John L. Faul, MD,a Tanya Wahl, MD,a Kai Ihnken, MD,b Gerald J. Berry, MD,c Ramona L. Doyle, MD,a and 
Richard I. Whyte, MD,b Stanford, Calif
The obstruction of blood flow from the head, neck, and
arms through the superior vena cava (SVC) results in the
SVC syndrome, which can lead to life-threatening complica-
tions such as circulatory failure, venous infarcts of the brain,
and laryngeal and cerebral edema.1 Most cases of SVC syn-
drome are due to inoperable malignant tumors, such as lung
cancer (80%) and mediastinal lymphomas (15%). SVC syn-
drome caused by leiomyosarcoma of the SVC has previously
been reported.2,3 This article describes a unique case of SVC
syndrome caused by pulmonary artery leiomyosarcoma, a
rare and highly lethal tumor.4 After treatment with radiation
and chemotherapy, the tumor was successfully resected and
the patient remains well 12 months later. 
Clinical summary. A 51-year-old white woman was
referred to this hospital for management of SVC syndrome.
Fourteen months earlier she had sought treatment at another
hospital for acute shortness of breath. A pulmonary angiogram
at that time showed complete obstruction of blood flow in the
pulmonary artery supplying the right lower lobe, and the
patient received streptokinase and heparin followed by war-
farin. There was no evidence of deep venous thrombosis, and
neither mammography nor abdominal computed tomography
(CT) indicated malignant disease. Three months later, a fol-
low-up thoracic CT scan demonstrated a persistent filling
defect in the right lower lobe pulmonary artery. Four days
before admission, facial swelling and plethora developed. On
the day of admission, the patient had nausea and headaches.
She worked as a secretary and did not drink or smoke. Her
medications included an oral contraceptive pill and warfarin. 
Physical examination revealed an ill-looking woman in
mild respiratory distress. Her pulse rate was 96 beats/min,
blood pressure 120/80 mm Hg, temperature 36.5°C, and res-
piratory rate 18 breaths/min. The face, neck, and arms were
red and swollen, and veins in the chest, neck, and face were
dilated. The trachea was in the midline and there was no evi-
dence of goiter or a neck mass. The heart sounds were normal
and the lungs were clear to auscultation and percussion.
There were no abdominal masses and no leg edema. Arterial
blood gas values were within normal limits. A chest radi-
ograph demonstrated a bulky tumor in the hilum of the right
lung and a small right pleural effusion. Thoracic magnetic
resonance imaging revealed a large (8 · 5 · 5 cm) well-cir-
cumscribed mass at the right hilum, surrounding the bronchus
intermedius, right main stem bronchus, and right lower lobe
bronchus (Fig 1). The tumor arose from the right pulmonary
artery, extended proximally almost to the bifurcation of the
main pulmonary artery, narrowed the SVC, and indented the
roof of the left atrium. Examination with a fiberoptic bron-
choscope revealed extrinsic compression of the right main
stem bronchus but no endobronchial lesion. CT-directed fine
needle aspiration biopsy of the mass yielded pleomorphic
malignant cells with prominent nucleoli and eosinophilic
cytoplasmic globules. Immunohistochemical reactivity
against desmin and smooth muscle actin confirmed smooth
muscle differentiation, with absence of staining for epithelial,
melanocytic, hematolymphoid, and vascular markers. A diag-
nosis of pulmonary artery leiomyosarcoma was made.
The patient underwent radiation therapy (4500 Gy) fol-
lowed by 3 cycles of ifosfamide (2500 mg/day for 3 days),
dacarbazine (490 mg/day for 3 days), and mesna (1000
mg/day for 4 days). Within 3 days of treatment the symptoms
of SVC syndrome had resolved, and within 4 weeks a second
CT scan showed that the tumor had shrunk to half its previ-
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Fig 1. The patient’s thoracic magnetic resonance imaging
venogram, demonstrating compression of the SVC by the
pulmonary artery sarcoma. 
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ous size. Three months after presentation, a right pneu-
monectomy was performed with resection of a predominant-
ly necrotic tumor, which involved the pulmonary artery,
extended into the lung, and surrounded the right main stem
bronchus (Fig 2). The tumor encased the right superior pul-
monary vein, and a cuff of left atrium was removed with the
lung. Cardiopulmonary bypass was available for the proce-
dure but was not necessary. Frozen section analysis of the
resection margin showed no tumor. On histologic examina-
tion of the resected specimen, only a microscopic focus of
viable tumor was found. The tissues within the pulmonary
artery lumen consisted of necrotic tumor, granulation tissue,
fibrosis, and macrophages indicative of treated leiomyosarco-
ma. The patient made a full recovery from the pneumonecto-
my and remains well 12 months later.
Discussion. Primary pulmonary artery leiomyosarcoma is
a rare and highly lethal disease. Although SVC syndrome
caused by intraluminal leiomyosarcoma of the SVC has pre-
viously been reported,2,3 to our knowledge this is a unique
case of SVC syndrome caused by pulmonary artery leio-
myosarcoma. Several cases of leiomyosarcoma of the pul-
monary artery have been described in which the clinical pre-
sentation mimics that of massive or chronic pulmonary
embolism.1,5 Pulmonary artery leiomyosarcoma may lead to
syncope and sudden death, and the diagnosis is therefore
often made at thoracotomy or at autopsy.1 Radical surgical
excision offers the only hope of cure for those with early,
resectable lesions.5
Successful treatment options for SVC syndrome include
thrombolysis, endovascular stent placement, radiotherapy, and
transluminal angioplasty, but the choice of therapy should be
directed toward treatment of the underlying cause, in addition
to alleviating symptoms.1 In this case of SVC syndrome caused
by advanced pulmonary artery leiomyosarcoma, combined
therapy with radiation and high-dose chemotherapy led to a
significant reduction in tumor bulk. The previously unre-
sectable tumor was then removed with a standard pneumonec-
tomy and the patient has had a good functional outcome. 
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Fig 2. Coronal section of the hilum of the right lower lobe of the lung. The lumen of the pulmonary artery is filled
and expanded by necrotic tumor (arrowheads).
